Immuron Limited Warrants (IMRNW) Stock Analysis

What Immuron Limited Warrants does

Immuron Limited, an Australian biopharmaceutical firm headquartered in Carlton and founded in 1994, is dedicated to the research, development, and market introduction of polyclonal antibodies. The company maintains a global presence, conducting operations across Australia, Israel, Canada, the United States, and other international territories. Its business activities are segmented into two core areas: Research and Development, and Hyperimmune Products. Immuron currently offers two main products: Travelan: An over-the-counter medication designed to mitigate the risk of travelers’ diarrhea and minor gastrointestinal discomfort. It also functions as a dietary supplement that supports digestive health and protects the gastrointestinal tract. Protectyn: An immune supplement aimed at fostering healthy digestive function and supporting liver vitality. In its development pipeline, Immuron is advancing several candidates: Travelan (IMM-124E): This version is specifically being developed for the U.S. market to reduce the risk of contracting travelers’ diarrhea. IMM-529: A therapeutic treatment for individuals experiencing recurring Clostridium difficile infections. The company has also established strategic collaborations, including a research agreement with the Naval Medical Research Center focused on developing and clinically evaluating a treatment for Campylobacter and enterotoxigenic Escherichia coli infections. Additionally, Immuron holds a collaborative agreement with the Walter Reed Army Institute of Research to create an oral therapeutic specifically for shigellosis.

Key metrics

ETFs linked to IMRNW

Broad-market and Healthcare sector ETFs an investor holding Immuron Limited Warrants is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how IMRNW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Immuron Limited Warrants?

Immuron Limited Warrants trades under the ticker IMRNW on NASDAQ.

Which exchange is IMRNW listed on?

IMRNW is listed on NASDAQ.

What sector does Immuron Limited Warrants operate in?

Immuron Limited Warrants is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze IMRNW in a portfolio?

PortView shows IMRNW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.